|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.38 USD | -1.44% |
|
-0.28% | +31.40% |
| 04-07 | California law limiting dialysis providers' profits voided by US appeals court | RE |
| 03-17 | R1 Therapeutics announces launch with an oversubscribed $77.5 million Series A financing | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 156.76 | 156.76 | 156.3 |
| Spread/Res. | -4.77% | -4.77% | -4.49% |
| Spread/Supp. | +2.54% | +16.61% | +15.55% |
| Support | 145.58 | 128.02 | 129.19 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- DVA Stock
- Charts DaVita Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition